RCUS Chart
- 52-Week Range: $17.23 - $48.47
- Market Capitalization: $1.51B
- Short Percentage: 0%
- Target Price: $57.20
- Shares Outstanding: 71.72M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RCUS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline UpdateBusiness Wire | April 26th
- Arcus Biosciences Presents Data from its Pipeline at Multiple Scientific ConferencesBusiness Wire | March 8th
- Arcus Biosciences to Participate in the Upcoming Investor ConferencesBusiness Wire | February 15th
- Arcus Biosciences: Not Much Data Yet, But Gilead Deal Is A Huge Value AddSeeking Alpha | January 7th
Company Info
Website: https://www.arcusbio.com
Address: 3928 Point Eden Way, Hayward, CA, United States, 94545
Sector: Healthcare
Industry: Biotechnology
Full time employees: 366
Address: 3928 Point Eden Way, Hayward, CA, United States, 94545
Sector: Healthcare
Industry: Biotechnology
Full time employees: 366
$RCUS Tomorrow
$RCUS take us to the moon
lets goooooo
$RCUS FYI - leaning bullish
$RCUS God dammit
$RCUS see you on the moon
$RCUS hot damn <3
$RCUS bear trap dude